ePrints

Glaucoma prescribing trends in England 2000 to 2012

Lookup NU author(s): Scott Fraser

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Purpose In 2009, the National Institute for Clinical Excellence (NICE) published guidance on the treatment of ocular hypertension and glaucoma. The aim of the present study was to describe the impact this guidance had on glaucoma prescribing and to describe recent prescribing trends in England.Method Prescribing cost analysis data held by NHS Business Authority for the years 2000-2012 was analysed.Results The number of prescriptions dispensed increased by 67% from 4.76 million in 2000 to 7.96 million in 2012. Over the same time period, drug costs increased by 88% from 55.2 pound million to 103.7 pound million. Prescriptions for prostaglandin analogues increased fourfold, while there was a threefold decrease in the use of beta-blockers. The most commonly prescribed glaucoma medication was latanoprost. The introduction of generic latanoprost in 2012 more than halved the cost associated with this medication. NICE guidance appeared to have had no effect on the total number of prescriptions or the classes of medications prescribed.Conclusion The introduction of the NICE guidelines did not change glaucoma prescribing practice, although it is not clear whether this represents non-adherence to the guidelines or whether the guidelines embodied pre-existing practice.

Publication metadata

Author(s): Connor AJ, Fraser SG

Publication type: Article

Publication status: Published

Journal: Eye

Year: 2014

Volume: 28

Issue: 7

Pages: 863-869

Print publication date: 01/07/2014

Online publication date: 23/05/2014

Acceptance date: 15/04/2014

ISSN (print): 0950-222X

ISSN (electronic): 1476-5454

Publisher: Nature Publishing Group

URL: http://dx.doi.org/10.1038/eye.2014.114

DOI: 10.1038/eye.2014.114

Altmetrics

Share